Skip to main content

Table 1 Baseline characteristics of adults with HIV infection, with and without acute myocardial infarction (AMI) receiving antiretroviral therapy in the Pharmetrics Plus data from October 2009 through December 2014 in the United States

From: Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States

Characteristics

All patients (N = 73,071), n (%)

Patients without AMI (N = 72,469), n (%)

Patients with AMI

(N = 602), n (%)

Age, median (IQR)

45 (38–52)

45 (38–52)

53 (48–59)

Male gender

59,514 (81.4)

58,981 (81.4)

533 (88.5)

Region

 East

17,523 (24.0)

17,354 (24.0)

169 (28.1)

 Mid-West

13,532 (18.5)

13,411 (18.5)

121 (20.1)

 South

33,271 (45.5)

33,014 (45.6)

257 (42.7)

 West

8745 (12.0)

8690 (12.0)

55 (9.1)

Year of ART initiation

 2009

24,435 (33.4)

24,127 (33.3)

308 (51.2)

 2010

9729 (13.3)

9636 (13.3)

93 (15.5)

 2011

10,274 (14.1)

10,190 (14.1)

84 (14.0)

 2012

8605 (11.8)

8559 (11.8)

46 (7.6)

 2013

7830 (10.7)

7794 (10.8)

36 (6.0)

 2014

12,198 (16.7)

12,163 (16.8)

35 (5.8)

Ever substance abuse

13,395 (18.3)

13,152 (18.2)

243 (40.4)

Ever alcohol abuse

3093 (4.2)

3039 (4.2)

54 (9.0)

Ever tobacco use

11,849 (16.2)

11,587 (16.0)

262 (43.5)

Body mass index > 24.9

1511 (2.07)

1503 (2.07)

8 (1.33)

Essential hypertension

7450 (10.2)

7336 (10.1)

114 (19.0)

Diabetes mellitus or receipt of anti-hyperglycemic agentsa

4128 (5.7)

4052 (5.6)

76 (12.6)

Chronic Kidney Disease

729 (1.0)

701 (1.0)

28 (4.7)

Dyslipidemia

8616 (11.8)

8496 (11.7)

120 (19.9)

Lipodystrophy

224 (0.3)

220 (0.3)

4 (0.7)

Pre-existing heart diseaseb

1754 (2.4)

1688 (2.3)

66 (11.0)

Receipt of medications for heart diseasec

14,336 (19.6)

14,074 (19.4)

262 (43.5)

History of stroke

211 (0.3)

204 (0.3)

7 (1.2)

Hepatitis B

959 (1.3)

953 (1.3)

6 (1.0)

Hepatitis C

1520 (2.1)

1500 (2.1)

20 (3.3)

History of cancer

5499 (7.5)

5442 (7.5)

57 (9.5)

  1. aSulfonylureas, biguanides, insulin, thiazolidinedione
  2. bPrior myocardial infarction, heart failure, cardiac arrhythmia, and atherosclerosis
  3. cAspirin, beta-blockers, calcium channel blockers, statins, angiotensin converting enzyme inhibitors, angiotensin receptor blockers